Nexien BioPharma, Inc.
NXEN · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $637 | $425 | $1,226 | $1,127 |
| - Cash | $8 | $1 | $5 | $4 |
| + Debt | $375 | $351 | $328 | $312 |
| Enterprise Value | $1,004 | $774 | $1,550 | $1,435 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | $0 | $0 | -$64 |
| % Margin | – | – | – | – |
| Net Income | -$30 | -$39 | -$32 | -$87 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0.001 | -0.001 | -0.001 |
| % Growth | 33.3% | -20% | 64.3% | – |
| Operating Cash Flow | -$13 | -$29 | -$9 | -$11 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$13 | -$29 | -$9 | -$11 |